{"title":"【碘己醇致药疹临床分析】。","authors":"M Akiyama, M Iijima, R Fujisawa","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>We reported 7 cases of drug eruption due to Iohexol (Omnipaque) which was nonionic X-ray contrast agent without severe adverse reaction. They showed generalized edematous and erythematous plaques. The eruption appeared from 5 to 6 days after the examination when a patient had not been sensitized, or several hours after that when he/she had been already sensitized. No case showed any cross-sensitization with ionic contrast media, but some cases suggested the possibility of cross-sensitization among the nonionic contrast agents.</p>","PeriodicalId":19167,"journal":{"name":"Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology","volume":"100 10","pages":"1057-60"},"PeriodicalIF":0.0000,"publicationDate":"1990-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Clinical analysis of drug eruption due to iohexol (Omnipaque)].\",\"authors\":\"M Akiyama, M Iijima, R Fujisawa\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We reported 7 cases of drug eruption due to Iohexol (Omnipaque) which was nonionic X-ray contrast agent without severe adverse reaction. They showed generalized edematous and erythematous plaques. The eruption appeared from 5 to 6 days after the examination when a patient had not been sensitized, or several hours after that when he/she had been already sensitized. No case showed any cross-sensitization with ionic contrast media, but some cases suggested the possibility of cross-sensitization among the nonionic contrast agents.</p>\",\"PeriodicalId\":19167,\"journal\":{\"name\":\"Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology\",\"volume\":\"100 10\",\"pages\":\"1057-60\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Clinical analysis of drug eruption due to iohexol (Omnipaque)].
We reported 7 cases of drug eruption due to Iohexol (Omnipaque) which was nonionic X-ray contrast agent without severe adverse reaction. They showed generalized edematous and erythematous plaques. The eruption appeared from 5 to 6 days after the examination when a patient had not been sensitized, or several hours after that when he/she had been already sensitized. No case showed any cross-sensitization with ionic contrast media, but some cases suggested the possibility of cross-sensitization among the nonionic contrast agents.